Enhanced drug delivery by a prodrug approach effectively
relieves neuroinflammation in mice

J 2022

Enhanced drug delivery by a prodrug approach effectively relieves neuroinflammation in mice

MONTASER, Ahmed B, Janita KUIRI, Teemu NATUNEN, Pavel HRUSKA, David POTĚŠIL et. al.

Basic information

Original name

Enhanced drug delivery by a prodrug approach effectively relieves neuroinflammation in mice

Authors

MONTASER, Ahmed B, Janita KUIRI, Teemu NATUNEN, Pavel HRUSKA, David POTĚŠIL (203 Czech Republic, guarantor, belonging to the institution), Seppo AURIOLA, Mikko HILTUNEN, Tetsuya TERASAKI, Marko LEHTONEN, Aaro JALKANEN and Kristiina M HUTTUNEN

Edition

Life Sciences, Amsterdam, Elsevier, 2022, 0024-3205

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 6.100

RIV identification code

RIV/00216224:14740/22:00128511

Organization unit

Central European Institute of Technology

DOI

http://dx.doi.org/10.1016/j.lfs.2022.121088

UT WoS

000880317300008

Keywords in English

Grid -hanging test; LAT1; LPS-induced neuroinflammation; Mouse brain proteome; Mouse membrane transporters; Rotarod

Abstract

V originále

Aims: Neuroinflammation is a prominent hallmark in several neurodegenerative diseases (NDs). Halting neu-roinflammation can slow down the progression of NDs. Improving the efficacy of clinically available non -steroidal anti-inflammatory drugs (NSAIDs) is a promising approach that may lead to fast-track and effective disease-modifying therapies for NDs. Here, we aimed to utilize the L-type amino acid transporter 1 (LAT1) to improve the efficacy of salicylic acid as an example of an NSAID prodrug, for which brain uptake and intra-cellular localization have been reported earlier.Main methods: Firstly, we confirmed the improved LAT1 utilization of the salicylic acid prodrug (SA-AA) in freshly isolated primary mouse microglial cells. Secondly, we performed behavioural rotarod, open field, and four-limb hanging tests in mice, and a whole-brain proteome analysis.Key findings: The SA-AA prodrug alleviated the lipopolysaccharide (LPS)-induced inflammation in the rotarod and hanging tests. The proteome analysis indicated decreased neuroinflammation at the molecular level. We identified 399 proteins linked to neuroinflammation out of 7416 proteins detected in the mouse brain. Among them, Gps2, Vamp8, Slc6a3, Slc18a2, Slc5a7, Rgs9, Lrrc1, Ppp1r1b, Gnal, and Adcy5/6 were associated with the drug's effects. The SA-AA prodrug attenuated the LPS-induced neuroinflammation through the regulation of critical pathways of neuroinflammation such as the cellular response to stress and transmission across chemical synapses.Significance: The efficacy of NSAIDs can be improved via the utilization of LAT1 and repurposed for the treatment of neuroinflammation. This improved brain delivery and microglia localisation can be applied to other inflam-matory modulators to achieve effective and targeted CNS therapies.

Links

LM2018127, research and development project

Name: Česká infrastruktura pro integrativní strukturní biologii (Acronym: CIISB)

Investor: Ministry of Education, Youth and Sports of the CR

LM2018140, research and development project

Name: e-Infrastruktura CZ (Acronym: e-INFRA CZ)

Investor: Ministry of Education, Youth and Sports of the CR

90127, large research infrastructures

Name: CIISB II

Citovat

MONTASER, Ahmed B, Janita KUIRI, Teemu NATUNEN, Pavel HRUSKA, David POTĚŠIL, Seppo AURIOLA, Mikko HILTUNEN, Tetsuya TERASAKI, Marko LEHTONEN, Aaro JALKANEN and Kristiina M HUTTUNEN. Enhanced drug delivery by a prodrug approach effectively relieves neuroinflammation in mice. Life Sciences. Amsterdam: Elsevier, 2022, vol. 310, DEC, p. 121088-121099. ISSN 0024-3205. Available from: https://dx.doi.org/10.1016/j.lfs.2022.121088.

@article{2252338,
   author = {Montaser, Ahmed B and Kuiri, Janita and Natunen, Teemu and Hruska, Pavel and Potěšil, David and Auriola, Seppo and Hiltunen, Mikko and Terasaki, Tetsuya and Lehtonen, Marko and Jalkanen, Aaro and Huttunen, Kristiina M},
   article_location = {Amsterdam},
   article_number = {DEC},
   doi = {http://dx.doi.org/10.1016/j.lfs.2022.121088},
   keywords = {Grid -hanging test; LAT1; LPS-induced neuroinflammation; Mouse brain proteome; Mouse membrane transporters; Rotarod},
   language = {eng},
   issn = {0024-3205},
   journal = {Life Sciences},
   title = {Enhanced drug delivery by a prodrug approach effectively relieves neuroinflammation in mice},
   url = {https://www.sciencedirect.com/science/article/pii/S0024320522007883?via%3Dihub},
   volume = {310},
   year = {2022}
}

TY  - JOUR
ID  - 2252338
AU  - Montaser, Ahmed B - Kuiri, Janita - Natunen, Teemu - Hruska, Pavel - Potěšil, David - Auriola, Seppo - Hiltunen, Mikko - Terasaki, Tetsuya - Lehtonen, Marko - Jalkanen, Aaro - Huttunen, Kristiina M
PY  - 2022
TI  - Enhanced drug delivery by a prodrug approach effectively relieves neuroinflammation in mice
JF  - Life Sciences
VL  - 310
IS  - DEC
SP  - 121088
EP  - 121088
PB  - Elsevier
SN  - 00243205
KW  - Grid -hanging test
KW  - LAT1
KW  - LPS-induced neuroinflammation
KW  - Mouse brain proteome
KW  - Mouse membrane transporters
KW  - Rotarod
UR  - https://www.sciencedirect.com/science/article/pii/S0024320522007883?via%3Dihub
N2  - Aims: Neuroinflammation is a prominent hallmark in several neurodegenerative diseases (NDs). Halting neu-roinflammation can slow down the progression of NDs. Improving the efficacy of clinically available non -steroidal anti-inflammatory drugs (NSAIDs) is a promising approach that may lead to fast-track and effective disease-modifying therapies for NDs. Here, we aimed to utilize the L-type amino acid transporter 1 (LAT1) to improve the efficacy of salicylic acid as an example of an NSAID prodrug, for which brain uptake and intra-cellular localization have been reported earlier.Main methods: Firstly, we confirmed the improved LAT1 utilization of the salicylic acid prodrug (SA-AA) in freshly isolated primary mouse microglial cells. Secondly, we performed behavioural rotarod, open field, and four-limb hanging tests in mice, and a whole-brain proteome analysis.Key findings: The SA-AA prodrug alleviated the lipopolysaccharide (LPS)-induced inflammation in the rotarod and hanging tests. The proteome analysis indicated decreased neuroinflammation at the molecular level. We identified 399 proteins linked to neuroinflammation out of 7416 proteins detected in the mouse brain. Among them, Gps2, Vamp8, Slc6a3, Slc18a2, Slc5a7, Rgs9, Lrrc1, Ppp1r1b, Gnal, and Adcy5/6 were associated with the drug's effects. The SA-AA prodrug attenuated the LPS-induced neuroinflammation through the regulation of critical pathways of neuroinflammation such as the cellular response to stress and transmission across chemical synapses.Significance: The efficacy of NSAIDs can be improved via the utilization of LAT1 and repurposed for the treatment of neuroinflammation. This improved brain delivery and microglia localisation can be applied to other inflam-matory modulators to achieve effective and targeted CNS therapies.
ER  -

MONTASER, Ahmed B, Janita KUIRI, Teemu NATUNEN, Pavel HRUSKA, David POTĚŠIL, Seppo AURIOLA, Mikko HILTUNEN, Tetsuya TERASAKI, Marko LEHTONEN, Aaro JALKANEN and Kristiina M HUTTUNEN. Enhanced drug delivery by a prodrug approach effectively relieves neuroinflammation in mice. \textit{Life Sciences}. Amsterdam: Elsevier, 2022, vol.~310, DEC, p.~121088-121099. ISSN~0024-3205. Available from: https://dx.doi.org/10.1016/j.lfs.2022.121088.

Detailed Information on Publication Record